Neurology · 1999 · 102 citations · 5 references
Life SciencesNeurologyNeuroscienceNeurobiology Of DiseaseNeurochemistryNeurodegenerationBiomarkers Of NeurodegenerationHuntington DiseaseMultiple System AtrophyNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersEnergy Metabolism DefectsHuntington Disease BiomarkersLipid Peroxidation MarkersNeurodegenerative Disease BiomarkersOxidative Damage BiomarkersOxidative Stress In NeurodegenerationOxidative Stress InjuryRedox Metabolism In Neurodegeneration
Numerous investigations using a variety of experimental model systems have suggested that oxidative stress in the context of impaired energy metabolism may be an important element in the pathogenesis of Huntington’s disease (HD).1 To test further the hypothesis that oxidative damage may contribute to the progression of HD, we measured a quantitative and specific marker of lipid peroxidation, F2-isoprostanes (F2-IsoP), in CSF from HD patients early in the course of disease. This was then compared with control subjects and patients with another degenerative disease of the basal ganglia that also has been associated with increased oxidative damage: multiple system atrophy—striatonigral degeneration type (MSA-P).2 Following informed consent, CSF was aspirated from the lumbar cistern, and 1 to 2 mL were immediately frozen at −80 °C and later used for F2-IsoP quantification as described.3 All CSF had protein and glucose concentrations as well as cell counts within normal ranges. Statistical comparisons were made with GraphPad Prism 2.0 software (San Diego, CA). Control subjects (n = 23) were hospitalized patients who underwent diagnostic evaluation …
5
Increased CSF F <sub>2</sub> -isoprostane concentration in probable AD
Thomas J. Montine, M. F. Beal, Merit Cudkowicz et al. · Neurology · 1999 · 250 citations
Trial of d-alpha-tocopherol in Huntington's disease
Carol E. Peyser, Marshal F. Folstein, G A Chase et al. · American Journal of Psychiatry · 1995 · 137 citations